Literature DB >> 19170709

Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.

Margaret F Keil1, Deborah P Merke, Roma Gandhi, Edythe A Wiggs, Kathy Obunse, Constantine A Stratakis.   

Abstract

OBJECTIVE: Cushing syndrome (CS) in children is associated with symptoms that may impair health related quality of life (HRQL). There are no prospective reports of HRQL in children with CS.
METHODS: Prospective study of 40 children (mean age 13 +/- 3.2 years) with CS evaluated prior to and 1-year post-treatment. The Child Health Questionnaire (CHQ) was used to assess HRQL; Wechsler Intelligence Scale for Children (WASI) was used to assess cognitive function, and patient-reported symptoms were assessed with a CS symptom checklist.
RESULTS: Active CS was associated with low physical and psychosocial summary scores compared to US population data (P < 0.001). Despite improvement from pre- to 1-year postcure, residual impairment remained in physical summary and function, and role-physical, global health and emotional impact (parent) scores. Incomplete recovery of adrenal function at 1-year post-treatment was associated with impaired scores. WASI IQ scores declined and a correlation was noted between age at first evaluation and IQ score changes. Most self-reported CS symptoms showed improvement, but forgetfulness, unclear thinking and decreased attention span did not improve after cure of CS.
CONCLUSION: CS in children and adolescents is associated with impaired HRQL, with residual impairment 1 year after cure. Our results also suggest that younger children are more likely to experience negative changes in cognitive function. HRQL is an important outcome measure in children and adolescents with CS and identification of factors that contribute to HRQL may help to diminish the physical and psychological burden of disease in this population of patients.

Entities:  

Mesh:

Year:  2008        PMID: 19170709      PMCID: PMC2755054          DOI: 10.1111/j.1365-2265.2008.03515.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  33 in total

1.  Cortisol, Cushing's Syndrome, and a shrinking brain-new evidence for reversibility.

Authors:  Bruce S McEwen
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

Review 2.  Diagnostic tests for Cushing's syndrome.

Authors:  Lynnette K Nieman
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

3.  Persistent cognitive impairment following surgical treatment of Cushing's syndrome.

Authors:  Hélène Forget; André Lacroix; Henri Cohen
Journal:  Psychoneuroendocrinology       Date:  2002-04       Impact factor: 4.905

4.  Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.

Authors:  S M Webb; X Badia; M J Barahona; A Colao; C J Strasburger; A Tabarin; M O van Aken; R Pivonello; G Stalla; S W J Lamberts; J E Glusman
Journal:  Eur J Endocrinol       Date:  2008-05       Impact factor: 6.664

5.  Incidence and late prognosis of cushing's syndrome: a population-based study.

Authors:  J Lindholm; S Juul; J O Jørgensen; J Astrup; P Bjerre; U Feldt-Rasmussen; C Hagen; J Jørgensen; M Kosteljanetz; L Kristensen; P Laurberg; K Schmidt; J Weeke
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

6.  Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin.

Authors:  P A Fitzgerald; D C Aron; J W Findling; R M Brooks; C B Wilson; P H Forsham; J B Tyrrell
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

7.  Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.

Authors:  Isabelle Bourdeau; Céline Bard; Bernard Noël; Isabelle Leclerc; Marie-Pierre Cordeau; Manon Bélair; Jacques Lesage; Lucie Lafontaine; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

8.  Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.

Authors:  Agatha A van der Klaauw; Marleen Kars; Nienke R Biermasz; Ferdinand Roelfsema; Olaf M Dekkers; Eleonora P Corssmit; Maarten O van Aken; Bas Havekes; Alberto M Pereira; Hanno Pijl; Johannes W Smit; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-29       Impact factor: 3.478

9.  Weight-specific health-related quality of life in adolescents with extreme obesity.

Authors:  Avani C Modi; Tara J Loux; Stephen K Bell; Carroll M Harmon; Thomas H Inge; Meg H Zeller
Journal:  Obesity (Silver Spring)       Date:  2008-07-17       Impact factor: 5.002

10.  Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales.

Authors:  James W Varni; Christine A Limbers; Tasha M Burwinkle
Journal:  Health Qual Life Outcomes       Date:  2007-07-16       Impact factor: 3.186

View more
  20 in total

Review 1.  Cushing syndrome: establishing a timely diagnosis.

Authors:  Judith Lowitz; Margaret F Keil
Journal:  J Pediatr Nurs       Date:  2015-02-24       Impact factor: 2.145

2.  Computerized Analysis of Brain MRI Parameter Dynamics in Young Patients With Cushing Syndrome-A Case-Control Study.

Authors:  Amit Tirosh; Harish RaviPrakash; Georgios Z Papadakis; Christina Tatsi; Elena Belyavskaya; Lyssikatos Charalampos; Maya B Lodish; Ulas Bagci; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

3.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

Review 4.  Cushing's Syndrome in Pediatrics: An Update.

Authors:  Maya B Lodish; Margaret F Keil; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

5.  Effects of Cushing disease on bone mineral density in a pediatric population.

Authors:  Maya B Lodish; Hui-Pin Hsiao; Anastasios Serbis; Ninet Sinaii; Anya Rothenbuhler; Margaret F Keil; Sosipatros A Boikos; James C Reynolds; Constantine A Stratakis
Journal:  J Pediatr       Date:  2010-03-10       Impact factor: 4.406

Review 6.  Cushing syndrome in pediatrics.

Authors:  Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2012-09-27       Impact factor: 4.741

7.  Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.

Authors:  R van der Pas; C de Bruin; A M Pereira; J A Romijn; R T Netea-Maier; A R Hermus; P M Zelissen; F H de Jong; A J van der Lely; W W de Herder; S M Webb; S W J Lamberts; L J Hofland; R A Feelders
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

Review 8.  Psychosomatic aspects of Cushing's syndrome.

Authors:  Nicoletta Sonino; Francesco Fallo; Giovanni A Fava
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 9.  Skin manifestations of Cushing's syndrome.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

10.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.